Personalized Immune Cell Treatment NKCL Classic
Potential for Growth in the Domestic Cell Therapy Market through the Application of Negative Regulation The Ministry of SMEs and Startups announced that on the 21st, it held the "Global Innovation Zone Launch Ceremony" at the Lotte Hotel in Jung-gu, Seoul, with representatives from local governments,...
[ NKCL participates as an anchor company in the Chungbuk Advanced Regenerative Bio Global Innovation Special Zone project ] In establishing a business plan for "Designation of Chungbuk Advanced Regenerative Bio Global Innovation Special Zone" announced last December, on January 19th, hosted by the Ch...
NKCL Bio Group Inc. (Chairman: Shin Dong-hwa) won the Innovation Management Technology Award at the '10th 2023 TV Chosun Management Awards,' announced on the 2nd, marking their consecutive win for the past two years in the technology innovation category. This award is a prestigious recognition given ...
NKCL Bio Group Inc. Receives 'Minister of Science and Technology Award' NKCL Bio Group Inc. (led by Chairman Shin Dong-hwa) declared on the 2nd that it secured the Minister of Science and ICT Award in the technology innovation category at the '10th 2023 TV Chosun Management Awards'. NKCL Bio Group In...
"Chairman Shin Dong-hwa: 'Leading Technology and Market in the Field of NK Cells to Enhance National Competitiveness'" "NKCL Bio Group (NKCL Bio Group Co., Ltd.) has won the 'Minister of Food and Drug Safety Award' in the R&D Management category at the 2023 National Empathy Management Awards. (Ph...
NKCL Bio Group, which has consistently contributed to the advancement of the bio industry in South Korea, including enhancing the nation’s competitiveness through innovative management activities, has been awarded the 2023 National Empathy Campaign ‘R&D Management’ sector. The group stated tha...
NKCL Bio Group announced on the 31st that it has obtained both CE certification and KC certification on the 27th for ‘RK-NKTM ACS (hereinafter referred to as ACS-I)’, an automatic single-person NK cell cultivator released this year. CE certification is an integrated standard certification mark mean...
NKCL Bio Group Inc. won the grand prize in the NK cell therapy category at the 17th ‘Korea Health Industry Awards’ in 2023 The Korea Health Industry Award, which provides an opportunity to spread awareness about the importance of the health industry, raises its status, and boosts morale in the heal...
NKCL Bio Group announced that it had recently acquired a patent for a stimulant composition for rapid testing of natural killer cell activity and a test method using the same. Ph.D. Shin Dong-hyeok of NKCL Bio Group said, “Normally, NK cells in our body are inactive, but they are activated and respo...
NKCL Bio Group Inc. won the ‘2023 Customer Love Brand Grand Prize’ in the immune care platform category. |Growing into a global top bio company in the K-Bio field through immune care platform services On May 16th, NKCL Bio Group Inc., a bio company that researches and develops NK immune cell therap...
